Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study

por Yousaf, Ahmed, Tjien‐Fooh, Félicia J., Rentroia‐Pacheco, Barbara, Quattrocchi, Enrica, Kobic, Ajdin, Tempel, Dennie, Kolodney, Michael, Meves, Alexander
Publicado 2021

Clinicopathologic models predicting non‐sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node?

por Rentroia‐Pacheco, Barbara, Tjien‐Fooh, Félicia J., Quattrocchi, Enrica, Kobic, Ajdin, Wever, Renske, Bellomo, Domenico, Meves, Alexander, Hieken, Tina J.
Publicado 2021

Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma

por Bellomo, Domenico, Arias-Mejias, Suzette M., Ramana, Chandru, Heim, Joel B., Quattrocchi, Enrica, Sominidi-Damodaran, Sindhuja, Bridges, Alina G., Lehman, Julia S., Hieken, Tina J., Jakub, James W., Pittelkow, Mark R., DiCaudo, David J., Pockaj, Barbara A., Sluzevich, Jason C., Cappel, Mark A., Bagaria, Sanjay P., Perniciaro, Charles, Tjien-Fooh, Félicia J., van Vliet, Martin H., Dwarkasing, Jvalini, Meves, Alexander
Publicado 2020